Stock Screener App

Frei -

Installieren

4.94

0.61% 0.03

Monte Rosa Therapeutics Inc (GLUE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GLUE? Forum Prognose

Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	72.69% 23.19	84.93	60.65	9.216	4.695
Operating Expenses	5.25% 38.75	40.89	47.64	35.74	37.34
Benefits Costs and Expenses	7.88% 34.29	37.22	45.05	33.00	34.75
Costs And Expenses	7.88% 34.29	37.22	45.05	33.00	34.75
Operating Income/Loss	135.32% -15.55	44.04	13.00	-26.53	-32.64
Nonoperating Income/Loss	21.44% 4.458	3.671	2.597	2.739	2.584
Income/Loss From Continuing Operations Before Tax	123.26% -11.10	47.71	15.60	-23.79	-30.06
Income Tax Expense/Benefit	45.86% 1.199	0.822	2.164	0.071	0.252
Income/Loss From Continuing Operations After Tax	126.22% -12.29	46.88	13.44	-23.86	-30.31
Net Income/Loss	126.22% -12.29	46.88	13.44	-23.86	-30.31
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.05% 82.19	82.15	2.7364	82.01	71.23
Diluted Average Shares	0.93% 82.19	82.96	2.7364	82.01	71.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters